Hostname: page-component-8448b6f56d-cfpbc Total loading time: 0 Render date: 2024-04-24T06:06:54.261Z Has data issue: false hasContentIssue false
  • English
  • Français

American Journal of Law & Medicine and Harvard Law & Health Care Society

Published online by Cambridge University Press:  01 January 2021

I. Glenn Cohen
Get access Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Recent Developments in Health Law
Information
Journal of Law, Medicine & Ethics , Volume 28 , Issue 3 , Fall 2000 , pp. 305 - 307
Copyright
Copyright © American Society of Law, Medicine and Ethics 2000

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

See “Clinical Research: Shalala Announces Plan to Strengthen Federal Oversight of Human Subjects Trials,” Health Law Reporter (BNA), 9 (May 25, 2000): At 800.Google Scholar
Id.Google Scholar
“The Belmont Report” (1979) § C(1). in Brody, B., The Ethics of Biomedical Research: An International Perspective (Oxford: Oxford University Press, 1998): 281–288Google Scholar
The interested reader is directed to Brody, , supra note 3, at 35–54Google Scholar
“Clinical Research: Shalala Announces” supra note 1, at 800. See also “Secretary Shalala Bolsters Protection for Human Subjects Research,” U.S. Department of Health and Services News (visited Oct. 9, 2000) <http://www.hhs.gov/news/press/2000pres/20000523.html>..>Google Scholar
“Declaration of Helsinki” (revised 1996) § I(5), in Brody, , supra note 3, at 214–216Google Scholar
“Clinical Research: Shalala Announces,” supra note 1, at 800Google Scholar
Id.Google Scholar
“Secretary Shalala Bolsters Protection for Human Subjects Research,” U.S. Department of Health and Services News (visited Oct. 9th 2000) <http://www.hhs.gov/news/press/2000pres/20000523.html>..>Google Scholar
“Clinical Research: Teaching Institutions Face Sharp Scrutiny of Patient Protections in Research Trials,” Health Law Reporter (BNA), 9 (Feb. 3, 2000): At 153.Google Scholar
Id.Google Scholar
“Clinical Research: Regulations to Increase Oversight of Clinical Gene Therapy,” Health Law Reporter (BNA), 9 (March 16, 2000): At 400Google Scholar
“Clinical Research: Teaching Institutions,” supra note 10, at 153.Google Scholar
Id.Google Scholar
Id.Google Scholar
Id.Google Scholar